Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain.

Hammond CJ, Hallock LR, Howanski RJ, Appelt DM, Little CS, Balin BJ.

BMC Neurosci. 2010 Sep 23;11:121. doi: 10.1186/1471-2202-11-121.

2.

Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain.

Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP.

FEMS Immunol Med Microbiol. 2006 Dec;48(3):355-66. Epub 2006 Oct 18.

3.

Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain.

Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP.

Med Microbiol Immunol. 1998 Jun;187(1):23-42.

PMID:
9749980
4.

Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice.

Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM.

Neurobiol Aging. 2004 Apr;25(4):419-29.

PMID:
15013562
5.

Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients.

Gieffers J, Reusche E, Solbach W, Maass M.

J Clin Microbiol. 2000 Feb;38(2):881-2.

6.

Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease.

Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gérard HC, Hudson AP.

J Alzheimers Dis. 2008 May;13(4):371-80. Review.

PMID:
18487846
7.

Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.

Bussière T, Bard F, Barbour R, Grajeda H, Guido T, Khan K, Schenk D, Games D, Seubert P, Buttini M.

Am J Pathol. 2004 Sep;165(3):987-95.

8.

Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.

Provias J, Jeynes B.

Curr Alzheimer Res. 2011 Mar;8(2):197-202.

PMID:
21143177
9.
10.

Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae.

Appelt DM, Roupas MR, Way DS, Bell MG, Albert EV, Hammond CJ, Balin BJ.

BMC Neurosci. 2008 Jan 24;9:13. doi: 10.1186/1471-2202-9-13.

11.

Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.

Luan K, Rosales JL, Lee KY.

Ageing Res Rev. 2013 Jan;12(1):174-81. doi: 10.1016/j.arr.2012.06.002. Epub 2012 Jun 19. Review.

PMID:
22728532
12.

Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain.

Ring RH, Lyons JM.

J Clin Microbiol. 2000 Jul;38(7):2591-4.

13.

Role of infection in Alzheimer's disease.

Balin BJ, Appelt DM.

J Am Osteopath Assoc. 2001 Dec;101(12 Suppl Pt 1):S1-6. Review.

PMID:
11794745
14.

Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.

Zhao Z, Ho L, Wang J, Qin W, Festa ED, Mobbs C, Hof P, Rocher A, Masur S, Haroutunian V, Pasinetti GM.

FASEB J. 2005 Dec;19(14):2081-2. Epub 2005 Sep 26.

PMID:
16186174
15.

Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains.

Tekirian TL, Cole GM, Russell MJ, Yang F, Wekstein DR, Patel E, Snowdon DA, Markesbery WR, Geddes JW.

Neurobiol Aging. 1996 Mar-Apr;17(2):249-57.

PMID:
8744406
16.

beta-Amyloid (A beta) deposition in the brains of aged orangutans.

Gearing M, Tigges J, Mori H, Mirra SS.

Neurobiol Aging. 1997 Mar-Apr;18(2):139-46.

PMID:
9258890
17.

Infiltration of the brain by pathogens causes Alzheimer's disease.

Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ.

Neurobiol Aging. 2004 May-Jun;25(5):619-27. Review.

PMID:
15172740
18.
19.
20.

IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.

Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA.

J Immunol. 2013 Mar 1;190(5):2241-51. doi: 10.4049/jimmunol.1200947. Epub 2013 Jan 30.

Supplemental Content

Support Center